ProSensa Holding N.V. Announces Second Quarter 2013 Financial Results and Recent Corporate Developments
Published: Aug 28, 2013
LEIDEN, The Netherlands, Aug. 28, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today reported financial results for the quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.